针对三阴性乳腺癌的个性化新抗原病毒免疫治疗平台
Renato Brito Baleeiro1, Peng Liu1, Louisa S Chard Dunmall1
1Centre for Cancer Biomarkers and Biotherapeutics, Queen Mary University of London, London, UK.
Journal for immunotherapy of cancer
|August 16, 2023
概括
这项研究开发了一种用于三阴性乳腺癌 (TNBC) 免疫治疗的新平台. 瘤性疫苗病毒 (VV) 提供免疫新抗原,成功诱导抗瘤CD8+T细胞,减缓瘤生长,并在临床前模型中改善生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 三重阴性乳腺癌 (TNBC) 预后不佳,转移潜力高.
- TNBC的高突变负载为基于新抗原的免疫疗法提供了机会.
- 一个关键的挑战是为疫苗开发确定有力的瘤特异性新抗原.
研究的目的:
- 建立一个平台,用于识别和提供TNBC的免疫新抗原.
- 使用型疫苗病毒 (VV) 作为TNBC新抗原疫苗的输送系统.
- 评估这种基于新抗原的疫苗策略的治疗潜力.
主要方法:
- 生物信息分析和基于细胞的测定被用来识别TNBC样本中的免疫新抗原.
- 在体外和体外T细胞测定评估了新抗原免疫性.
- 临床前TNBC模型被用于评估新抗原疫苗接种与瘤性VV的疗效.
主要成果:
- 鉴定出免疫性新抗原,产生新抗原特异性CD8+T细胞.
- 瘤性VV调节了瘤微环境,增强了树突细胞和T细胞.
- 使用新抗原和瘤性VV的prime/boost疗法减缓了瘤生长,增加了存活率.
结论:
- 这项研究提出了一种有前途的基于新抗原的TNBC免疫疗法方法.
- 开发的平台有效地诱导新抗原特异性CD8+T细胞反应.
- 需要进一步的临床试验来评估安全性和有效性.
相关概念视频
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


